Home › Stocks › RCUS

Arcus Biosciences, Inc. (RCUS): insider buying, hedge funds & Congress trades

Arcus Biosciences, Inc. (RCUS): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Feb 27, 2025Rosen Terry J
Director, Officer
19,800$10.18$201.6Kno history
Feb 27, 2025Kaneko Yasunori
Director
20,000$10.06$201.2Kno history
Feb 20, 2025Gilead Sciences, Inc.
TenPercentOwner
1,363,636$11.00$15.0Mno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for RCUS

Free account. Know when insiders, famous funds or Congress trade it.

Start free